GE HealthCare Technologie... (GEHCV)
NASDAQ: GEHCV
· Real-Time Price · USD
56.00
-2.38 (-4.08%)
At close: Jan 04, 2023, 6:00 AM
GE HealthCare Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Dec 31, 2021 |
Cash & Equivalents | 3.76B | 2.47B | 2.89B | 3.57B | 2.02B | 2.42B | 1.94B | 2.33B | 1.45B | 498M | 554M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 341M |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.57B | 2.34B | 1.99B |
Receivables | 3.56B | 3.57B | 3.56B | 3.42B | 3.34B | 3.37B | 3.37B | 3.37B | 4.3B | 3.65B | 3.79B |
Inventory | 2.28B | 2.16B | 1.94B | 2.12B | 2.02B | 2.13B | 2.26B | 2.26B | 2.15B | 2.2B | 1.95B |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 417M | 935M | 709M |
Total Current Assets | 9.61B | 8.2B | 8.39B | 9.11B | 7.38B | 7.92B | 7.57B | 7.96B | 8.32B | 7.28B | 7B |
Property-Plant & Equipment | 2.96B | 2.85B | 2.55B | 2.54B | 2.46B | 2.35B | 2.36B | 2.33B | 2.31B | 2.08B | 2.23B |
Goodwill & Intangibles | 14.64B | 14.61B | 14.21B | 14.27B | 14.31B | 14.25B | 14.35B | 14.42B | 14.33B | 14.37B | 14.74B |
Total Long-Term Assets | 22.12B | 21.92B | 21.24B | 21.12B | 21.13B | 20.88B | 21.06B | 21.08B | 19.22B | 18.79B | 19.31B |
Total Assets | 35.5B | 33.59B | 33.09B | 33.85B | 31.85B | 32.38B | 32.09B | 32.43B | 27.54B | 26.07B | 26.31B |
Account Payables | 2.98B | 3.15B | 3.02B | 2.91B | 2.82B | 2.77B | 2.83B | 2.98B | 2.94B | 2.69B | 2.54B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.9B | 1.76B | 1.86B |
Short-Term Debt | 2B | 2B | 1.5B | 1.01B | 1.01B | 7M | 5M | 5M | 15M | 12M | 110M |
Other Current Liabilities | 7.74B | 7.97B | 8.05B | 7.66B | 4.49B | 4.78B | 4.74B | 5.25B | 2.34B | 2.17B | 2.25B |
Total Current Liabilities | 9.75B | 9.97B | 9.55B | 8.67B | 8.32B | 7.57B | 7.58B | 8.24B | 7.19B | 6.63B | 6.76B |
Long-Term Debt | n/a | n/a | n/a | n/a | 8.23B | 10.25B | 10.23B | 10.23B | 8.23B | 31M | 327M |
Other Long-Term Liabilities | 15.63B | 14.04B | 14.83B | 16.61B | 7.25B | 7.2B | 7.09B | 7.21B | 2.38B | 1.96B | 1.31B |
Total Long-Term Liabilities | 15.8B | 14.2B | 14.88B | 16.67B | 15.54B | 17.51B | 17.41B | 17.5B | 10.99B | 2.36B | 2.65B |
Total Liabilities | 25.55B | 24.17B | 24.44B | 25.34B | 23.86B | 25.08B | 24.99B | 25.74B | 18.18B | 8.99B | 9.41B |
Total Debt | 2B | 2B | 1.5B | 1.01B | 9.24B | 10.26B | 10.24B | 10.24B | 8.25B | 43M | 437M |
Common Stock | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | n/a | n/a | n/a |
Retained Earnings | 4.29B | 3.81B | 3.26B | 2.56B | 2.1B | 937M | 576M | 185M | n/a | n/a | n/a |
Comprehensive Income | -1.09B | -1.2B | -1.38B | -771M | -845M | -280M | 70M | 75M | -1.88B | -1.94B | -1.04B |
Shareholders Equity | 9.71B | 9.19B | 8.45B | 8.32B | 7.8B | 7.13B | 7.1B | 6.69B | 9.36B | 16.86B | 16.66B |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 341M |